Clin2
NCT06001749Possibly a fitRecruiting

Psilocybin for cancer pain study

Opioid-Related DisordersPain ManagementPain Management and CareAdvanced CancerAdvanced Cancers

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This trial tests whether psilocybin (a psychedelic drug) can help with severe cancer pain. You may qualify if your pain is high despite strong medications and you are willing to be monitored closely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
15 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • Your cancer is advanced and not likely to be cured or controlled.
  • Your average pain is at least a 4 out of 10 in the past week.
  • You are taking strong pain medicine (opioids) equal to 200 mg of morphine or more each day.
  • You have seen a palliative care doctor at Dana-Farber or Massachusetts General Hospital in the last 3 months.
  • You are able to swallow pills and have a support person who can be contacted if needed.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05398484Recruiting· Phase 2/Phase 3
Psilocybin therapy for advanced cancer-related anxiety

This trial studies whether psilocybin (with support and therapy) can reduce anxiety in people with advanced cancer. It may help with distress and quality of life, while the study team monitors safety closely.

Aurora, Colorado
NCT06731335Recruiting· Phase 2
Psilocybin for chronic nerve pain that hasn't improved with other treatments

This study tests whether psilocybin (a compound found in certain mushrooms) can help reduce chronic nerve pain that has not responded well to standard medications. You will receive study treatment plus psychotherapy to see if it improves your pain.

Toronto, Ontario
NCT06200155Recruiting· Phase 2
Psilocybin therapy for advanced cancer patients with anxiety or depression

This trial tests whether a drug called psilocybin, given with therapy, can help people with advanced cancer who are feeling anxious or depressed. You must have a stable cancer and be willing to travel to Houston for treatment.

Houston, Texas
NCT07406828Not yet recruiting· Phase 1
Psilocybin after trauma surgery for pain

This trial tests whether psilocybin (a psychedelic substance) can help manage pain after a trauma surgery for people with a history of opioid addiction. You'd receive a single dose in the hospital and be monitored for 8 hours.

Pittsburgh, Pennsylvania
NCT07791901Not yet recruiting· Phase 2
Psilocybin therapy for demoralization in advanced cancer

This study tests whether psilocybin (a hallucinogen) combined with psychological support can help reduce feelings of hopelessness and loss of meaning in people with advanced cancer. It aims to see if this treatment can improve emotional well-being and quality of life.

Calgary, Alberta
NCT07118332Recruiting· Early Phase 1
Psilocybin for chronic pain in veterans who smoke

This trial tests if psilocybin can help veterans with chronic pain who also smoke cigarettes. You will take psilocybin in a controlled setting to see if it reduces pain and helps with smoking.

West Haven, Connecticut

Hear when a new Opioid-Related Disorders trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.